Bright Senyo Ashimatey

Company: Apellis Pharmaceuticals
Job title: Clinical Research and Development Scientist
Seminars:
Exploring Neurologic Disease Pathways Via Retinal Vascular Biomarkers to Accelerate Detection 12:00 pm
Quantifying retinal putative glial alterations as a potential indicator of vascular dysregulation in neurologic disease Insights from OCTA for characterizing retinal vascular dysregulation using diabetic retinopathy as a model Understanding the contribution of vascular dysregulation in neurologic disease using OCTA biomarkers as windowRead more
day: Conference Day Two